Market Access Women in IP: Why women with science degrees should consider ... Intellectual property (IP) is a multifaceted sector that offers opportunities across a range of subjects.
Market Access Reuters Pharma Barcelona 2023 - Day 3 Day Three arrives and Reuters Pharma 2023 comes to a close – but not before Boehringer Ingelheim talks to us about accelerating time-to-patient and an expert panel discusses empowering a wh
Market Access Sponsored Navigating Routes to Commercial Excellence in Cell and Gene ... 'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.
Market Access Why ‘reduce, reuse, and recycle' medicine is the future The ultimate raison d’être of any medicine is to benefit patients.
Market Access What the low impact of Humira biosimilars teaches us about d... Almost everyone seems to agree that drug prices are too high.
Market Access The secret to enrolling more women in clinical research Women are still underrepresented in clinical research.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
